NCT06451172View on ClinicalTrials.gov

Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 11, 2023

Primary Completion Date

October 1, 2024

Study Completion Date

October 31, 2026

Conditions
Bacterial KeratitisAntibiotic-resistant BacteriaInfections, BacterialCorneal DiseasesEye DiseasesVision DisordersSensation DisordersBlindnessAntisense Peptide Nucleic AcidAntibacterial Therapy
Interventions
DRUG

ASO

Anticipated 20 Participants will receive a single group administered via eye drops in the study eye.

Trial Locations (1)

200031

RECRUITING

Eye & ENT Hospital of Fudan University, Shanghai

All Listed Sponsors
lead

Eye & ENT Hospital of Fudan University

OTHER

collaborator

Soochow University

OTHER